Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2000
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants ; volume:24 ; number:4 ; day:22 ; month:6 ; year:2020 ; pages:505 ; date:8.2020
Molecular diagnosis & therapy ; 24, Heft 4 (22.6.2020), 505, 8.2020
- Creator
-
Pestinger, Valerie
Smith, Matthew
Sillo, Toju
Findlay, John M.
Laes, Jean‑Francois
Martin, Gerald
Middleton, Gary
Taniere, Phillipe
Beggs, Andrew D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40291-020-00479-2
- URN
-
urn:nbn:de:101:1-2020091119554743125999
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pestinger, Valerie
- Smith, Matthew
- Sillo, Toju
- Findlay, John M.
- Laes, Jean‑Francois
- Martin, Gerald
- Middleton, Gary
- Taniere, Phillipe
- Beggs, Andrew D.
- SpringerLink (Online service)
Other Objects (12)
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Mutational and non mutational adaptation of Salmonella enterica to the gall bladder
Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
Applying machine learning to dervive actionable insights in precision oncology
Applying machine learning to derive actionable insights in precision oncology
Machine actionable metadata models
Next-Generation Sequencing Analysis of Cell-Free DNA Identifies Actionable Alterations and Genomic Features in Pediatric Cancers
Next-generation sequencing-based clinical diagnosis of choroideremia and comprehensive mutational and clinical analyses
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Mutational and non mutational adaptation of Salmonella enterica to the gall bladder
Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
Applying machine learning to dervive actionable insights in precision oncology
Applying machine learning to derive actionable insights in precision oncology
Machine actionable metadata models
Next-Generation Sequencing Analysis of Cell-Free DNA Identifies Actionable Alterations and Genomic Features in Pediatric Cancers
Next-generation sequencing-based clinical diagnosis of choroideremia and comprehensive mutational and clinical analyses
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Mutational and non mutational adaptation of Salmonella enterica to the gall bladder
Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
Applying machine learning to dervive actionable insights in precision oncology
Applying machine learning to derive actionable insights in precision oncology
Machine actionable metadata models
Next-Generation Sequencing Analysis of Cell-Free DNA Identifies Actionable Alterations and Genomic Features in Pediatric Cancers